CClinicalTrials.gg
RecruitingNCT06597617PERSIST-APAUpdated Mar 25, 2025

Persistent Organic Pollutants and Mechanical Discharge: Limiting the Impact of Bariatric Surgery Through Personalized Adapted Physical Activity

An interventional study of Adapted physical activity with aerobic training [GEA] and Adapted physical activity with strength training [GRM] in Obesity and Bariatric Surgery Candidate, sponsored by Centre Hospitalier Universitaire de Nice. Recruiting at 1 site in France. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-03-25.

Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

For the most severe cases of obesity, recourse to bariatric surgery is the ultimate solution. Although highly beneficial to individual health, this massive loss of body mass could also have negative effects on metabolism and neuromuscular function. Unfortunately, these effects have been relatively little studied in the scientific literature, and are poorly taken into account in patient follow-up when bariatric surgery has been recommended. One of the adverse effects of bariatric surgery is the release into the bloodstream of Persistent Organic Pollutants (POPs) which, are not only persistent, but also bioaccumulative, toxic and mobile. The major problem is that these circulating POPs are linked to a number of adverse side effects, including reproductive disorders, neurobehavioral alterations, metabolic disorders, gut microbiota alterations inflammatory changes and physiological alterations. POP neurotoxicity could also affect psychomotor abilities and neuromuscular function. In addition, the mechanical unloading (i.e., reduced mechanical stress on muscles) induced by loss of body mass, an effect targeted by bariatric surgery and largely beneficial to the health of individuals, could also alter neuromuscular function and potentially alter muscle architecture and contractile properties. Unfortunately, no data are currently available in the scientific literature to confirm or refute these hypotheses. Physical activity-based intervention strategies may be usefull to counteract the effects of mechanical unloading and the release of POPs as suggested in scientific literature. However it is also possible to question which exercise modality should be preferred. Our hypothesis is that eccentric muscle strengthening would better preserve muscle mass and neuromuscular function while limiting the risks associated with POPs release, compared with an aerobic and a control group.

02

Conditions studied

  • Obesity
  • Bariatric Surgery Candidate
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 709 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patient (18-55 years)
  • Patient scheduled for bariatric surgery
  • Patient practicing a leisure-time physical activity \< 8 hours of moderate intensity per week or \< 4 hours of high intensity per week
  • Presence of effective contraception (hormonal or mechanical)

Exclusion criteria

Exclusion Criteria:

  • Patient already involved in another experimental study
  • Pregnant (urine pregnancy test) or breast-feeding women
  • Patient in a particular situation deemed incompatible with the study by the investigator
  • Patients from outside the Alpes-Maritimes and Var departments
  • Patient having received antibiotic treatment during the 3 months preceding the first stool collection
  • Presence of a contraindication to adapted physical activity
  • Presence of a contraindication to neurostimulation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Group Control
  • Experimental
    GEA (Aerobic training)

    Behavioral: Adapted physical activity with aerobic training [GEA]

  • Experimental
    GRM (Strength training)

    Behavioral: Adapted physical activity with strength training [GRM]

Interventions

  • BehavioralAdapted physical activity with aerobic training [GEA]

    Participants will be required to take part in 3 weekly sessions of adapted physical activity for 3 months following bariatric surgery. These sessions (not exceeding 1 hour and 10 minutes) will focus on aerobic training. The first 3 sessions will be accompanied, and will take place either by videoconference or face-to-face, depending on the patient's wishes. Thereafter, each 1st session of the following weeks will also be accompanied and carried out either by videoconference or face-to-face. The following 2 sessions of the week will be carried out autonomously. Each session will be organized into (i) a 5-minute cardio-respiratory warm-up and joint mobilization, (ii) a block of aerobic activity and (iii) a 2-minute cool-down including breathing exercises. Training will take place in 2 phases. The first phase will involve a total of 90 minutes of aerobic training spread over 3 sessions. The second phase will involve a total of 150 minutes of aerobic training over 3 sessions.

  • BehavioralAdapted physical activity with strength training [GRM]

    Participants will be required to take part in 3 weekly sessions of adapted physical activity for 3 months following bariatric surgery. These sessions (not exceeding 1 hour and 10 minutes) will focus on eccentric training. The first 3 sessions will be accompanied and conducted face-to-face. Thereafter, each 1st session of the following weeks will also be accompanied and carried out face-to-face. The following 2 sessions of the week will be carried out autonomously. Each session will be organized into (i) a 5-minute cardio-respiratory warm-up and joint mobilization, (ii) muscle-strengthening exercises and (iii) a 2-minute cool-down including breathing exercises. The exercises used will mainly involve the lower limbs. Training will take place in 2 phases. The first phase will involve an exposure/adaptation phase to eccentric training. The second phase will involve a gradual increase in intensity.

06

What researchers measure

Primary outcomes

  1. MVC (Maximum Voluntary Contraction)

    Unit used to quantify MVC (Maximum Voluntary Contraction): Nm. Description: MVC will be obtained using an ergometer and force sensors.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  2. Blood concentration for each POP investigated

    Unit used to quantify blood concentration for each POP (Persistent Organic Pollutant) investigated: ng/g of lipid.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Secondary outcomes

  1. Total POPs blood concentration [∑POPs]

    Total POPs blood concentration \[∑POPs\] (ng/ml) will be obtained with the analysis of a blood sampling by chromatography and spectrometry.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  2. Quantity by POPs category

    Quantity by POPs category (ng/ml) will be obtained with the analysis of a blood sampling by chromatography and spectrometry.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  3. Specific and relative muscle strength

    Specific and relative muscle strength (N m) will be obtained using an ergometer and force sensors.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  4. M-wave

    M-wave will be obtained using an EMG device.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  5. NAV [Voluntary Activation Level]

    NAV \[Voluntary Activation Level\] (%) will be obtained using an ergometer, force sensors and a stimulator device

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  6. Fatigability

    Fatigability (Δ N m) will be obtained using an ergometer, force sensors and a muscular fatigue protocol.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  7. Pennation angle

    Pennation angle (°) will be obtained by muscle ultrasound imaging.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  8. Muscle thickness

    Muscle thickness (mm) will be obtained by muscle ultrasound imaging.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  9. Fascicle length

    Fascicle length (mm) will be obtained by muscle ultrasound imaging.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  10. Characterization of gut microbiota

    Alpha and beta diversity will be obtained by the analysis of feces collected with specific sampling kit.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  11. Weight

    Weigh (kg) will be obtained by using a weight balance.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  12. Fat mass

    Fat mass (kg and %) will be obtained by using an impedancemeter.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  13. Lean mass

    Lean mass (kg and %) will be obtained by using an impedancemeter.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  14. Body mass index (BMI)

    Body mass index (kg/m\^2) will be obtained by using weight balance and a height chart.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  15. Waist-to-hip ratio

    Waist-to-hip ratio will be obtained by measuring the waist circumference (cm) and the hip circumference (cm) with the WHO protocol.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  16. Total cholesterol

    Total cholesterol (g/l) will be obtained with blood sampling analysis.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  17. Free cholesterol

    Free cholesterol (g/l) will be obtained with blood sampling analysis.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  18. Total intra-serum lipids

    Total intra-serum lipids (g/l) will be obtained with blood sampling analysis.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  19. Phospholipids

    Phospholipids (g/l) will be obtained with blood sampling analysis.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

  20. Triglycerides

    Triglycerides (g/l) will be obtained with blood sampling analysis.

    Time frame: One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06597617
Lead sponsor
Centre Hospitalier Universitaire de Nice
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Jun 2025 (estimated)
Primary completion
Jun 2028 (estimated)
Completion
Oct 2028 (estimated)
Last update
Mar 25, 2025

Study contacts

Nicolas CHEVALIER, Pr
Contact
chevalier.n@chu-nice.fr
04 92 03 67 55 ext. +33
Nicolas CHEVALIER, Pr
principal investigator · Centre Hospitalier Universitaire de Nice

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion